Sign inGet started

Hanson James S.

Insider CIK 1744887 · GTHX General Counsel · FTRE General Counsel

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FTRE Fortrea Holdings Inc. S Sale2025-09-092025-09-101,677$10.23 $17.2K19,092SEC↗
FTRE Fortrea Holdings Inc. M Exercise deriv2025-09-082025-09-105,788— $047,167SEC↗
FTRE Fortrea Holdings Inc. M Exercise2025-09-082025-09-105,788— $020,769SEC↗
FTRE Fortrea Holdings Inc. S Sale2025-06-032025-06-042,191$4.17 $9.1K14,981SEC↗
FTRE Fortrea Holdings Inc. M Exercise deriv2025-06-022025-06-047,706— $052,955SEC↗
FTRE Fortrea Holdings Inc. M Exercise2025-06-022025-06-047,706— $017,172SEC↗
FTRE Fortrea Holdings Inc. S Sale2025-03-142025-03-171,007$9.70 $9.8K9,466SEC↗
FTRE Fortrea Holdings Inc. M Exercise deriv2025-03-132025-03-172,998— $060,661SEC↗
FTRE Fortrea Holdings Inc. M Exercise2025-03-132025-03-172,998— $010,473SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2025-03-072025-03-1027,668— $063,659SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2025-03-062025-03-1011,577— $035,991SEC↗
FTRE Fortrea Holdings Inc. P Buy2024-06-122024-06-122,000$25.30 $50.6K7,475SEC↗
FTRE Fortrea Holdings Inc. M Exercise deriv2024-06-032024-06-037,706— $024,414SEC↗
FTRE Fortrea Holdings Inc. M Exercise2024-06-032024-06-037,706— $07,706SEC↗
FTRE Fortrea Holdings Inc. F Tax w/h2024-06-032024-06-032,231$24.85 $55.4K5,475SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2024-03-132024-03-158,996— $032,120SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2023-06-302023-07-0520,702— $020,702SEC↗
FTRE Fortrea Holdings Inc. A Award deriv2023-06-302023-07-1923,124— $023,124SEC↗
FTRE Fortrea Holdings Inc. J Other2023-06-202023-06-2125— $025SEC↗
GTHX G1 Therapeutics, Inc. S Sale2023-01-052023-01-05729$5.41 $3.9K41,087SEC↗
GTHX G1 Therapeutics, Inc. S Sale2023-01-042023-01-051,639$5.58 $9.1K41,816SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2023-01-032023-01-0535,700— $035,700SEC↗
GTHX G1 Therapeutics, Inc. A Award2023-01-032023-01-0517,900— $043,455SEC↗
GTHX G1 Therapeutics, Inc. S Sale2022-01-052022-01-051,445$10.61 $15.3K25,555SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2022-01-032022-01-0553,000— $053,000SEC↗
GTHX G1 Therapeutics, Inc. A Award2022-01-032022-01-0512,000— $027,000SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2021-01-042021-01-0558,000— $058,000SEC↗
GTHX G1 Therapeutics, Inc. A Award2021-01-042021-01-0511,000— $015,000SEC↗
GTHX G1 Therapeutics, Inc. P Buy2020-09-042020-09-081,000$14.95 $14.9K4,000SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2020-02-062020-02-0760,000— $060,000SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2019-01-022019-01-0260,000— $060,000SEC↗
GTHX G1 Therapeutics, Inc. P Buy2018-12-262018-12-271,000$18.25 $18.3K3,000SEC↗
GTHX G1 Therapeutics, Inc. P Buy2018-12-102018-12-111,000$32.51 $32.5K2,000SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2018-06-252018-06-27140,000— $0140,000SEC↗